MedPath

Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

Terminated
Conditions
Alpha 1-Antitrypsin Deficiency
Registration Number
NCT00005098
Lead Sponsor
National Center for Research Resources (NCRR)
Brief Summary

OBJECTIVES:

I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.

Detailed Description

PROTOCOL OUTLINE:

Patients undergo blood draw and skin biopsy. Cells are isolated from patients' blood and skin, cell lines are established, and genetic traits are examined.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children's Hospital of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath